Oracle Co. (NYSE:ORCL) Shares Sold by Physicians Financial Services Inc.

Physicians Financial Services Inc. reduced its position in Oracle Co. (NYSE:ORCL) by 1.3% in the 3rd quarter, Holdings Channel reports. The firm owned 23,668 shares of the enterprise software provider’s stock after selling 300 shares during the quarter. Oracle accounts for about 1.3% of Physicians Financial Services Inc.’s portfolio, making the stock its 24th largest position. Physicians Financial Services Inc.’s holdings in Oracle were worth $4,033,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the business. Fairway Wealth LLC acquired a new position in shares of Oracle during the 2nd quarter valued at about $27,000. POM Investment Strategies LLC purchased a new position in Oracle during the second quarter worth about $30,000. Bbjs Financial Advisors LLC acquired a new position in Oracle in the 2nd quarter valued at about $35,000. Reston Wealth Management LLC acquired a new stake in shares of Oracle during the 3rd quarter worth approximately $44,000. Finally, Quest Partners LLC purchased a new stake in shares of Oracle during the 2nd quarter valued at approximately $40,000. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Oracle Stock Up 1.2 %

Shares of ORCL traded up $2.32 during mid-day trading on Friday, reaching $188.69. The company’s stock had a trading volume of 971,737 shares, compared to its average volume of 8,248,296. The company’s 50 day moving average is $165.58 and its 200 day moving average is $143.29. The company has a debt-to-equity ratio of 6.68, a current ratio of 0.72 and a quick ratio of 0.72. The stock has a market cap of $522.87 billion, a PE ratio of 48.02, a price-to-earnings-growth ratio of 3.12 and a beta of 1.02. Oracle Co. has a 12-month low of $99.26 and a 12-month high of $188.74.

Oracle (NYSE:ORCL) last issued its quarterly earnings data on Monday, September 9th. The enterprise software provider reported $1.39 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.06. Oracle had a net margin of 20.40% and a return on equity of 171.38%. The business had revenue of $13.31 billion during the quarter, compared to the consensus estimate of $13.23 billion. During the same quarter in the previous year, the firm earned $0.95 EPS. The company’s revenue was up 6.9% compared to the same quarter last year. Equities analysts anticipate that Oracle Co. will post 5 EPS for the current fiscal year.

Oracle Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, October 24th. Stockholders of record on Thursday, October 10th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.85%. The ex-dividend date of this dividend was Thursday, October 10th. Oracle’s dividend payout ratio (DPR) is currently 41.24%.

Insider Activity

In other Oracle news, EVP Maria Smith sold 6,320 shares of the business’s stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $165.00, for a total value of $1,042,800.00. Following the completion of the sale, the executive vice president now owns 42,889 shares in the company, valued at approximately $7,076,685. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 42.20% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. JMP Securities increased their price objective on Oracle from $175.00 to $205.00 and gave the stock a “market outperform” rating in a research report on Friday, October 18th. Bank of America raised their price objective on Oracle from $155.00 to $175.00 and gave the stock a “neutral” rating in a research report on Tuesday, September 10th. StockNews.com upgraded shares of Oracle from a “hold” rating to a “buy” rating in a research report on Monday. Melius Research upgraded shares of Oracle from a “hold” rating to a “buy” rating in a report on Monday, September 16th. Finally, Mizuho lifted their target price on shares of Oracle from $170.00 to $185.00 and gave the company an “outperform” rating in a report on Tuesday, September 10th. Eleven analysts have rated the stock with a hold rating and twenty have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $168.52.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.